Search Results

CYT997 5mg 5mg  | Purity Not Available

Adooq Bioscience

CYT997 is a novel anti-cancer vascular disrupting agent (VDA). In vitro, CYT997 is shown to potently inhibit the proliferation of vascular endothelial growth factor-stimulated human umbilical vein endothelial cells (IC(50) 3.7 ?? 1.8 nM) and cause significant morphological changes at 100 nM, including membrane blebbing.

More Information Supplier Page

CYT997 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

CYT997 is a novel anti-cancer vascular disrupting agent (VDA). In vitro, CYT997 is shown to potently inhibit the proliferation of vascular endothelial growth factor-stimulated human umbilical vein endothelial cells (IC(50) 3.7 ?? 1.8 nM) and cause significant morphological changes at 100 nM, including membrane blebbing.

More Information Supplier Page

CYT997 100mg 100mg  | Purity Not Available

Adooq Bioscience

CYT997 is a novel anti-cancer vascular disrupting agent (VDA). In vitro, CYT997 is shown to potently inhibit the proliferation of vascular endothelial growth factor-stimulated human umbilical vein endothelial cells (IC(50) 3.7 ?? 1.8 nM) and cause significant morphological changes at 100 nM, including membrane blebbing.

More Information Supplier Page

CYT997 10mg 10mg  | Purity Not Available

Adooq Bioscience

CYT997 is a novel anti-cancer vascular disrupting agent (VDA). In vitro, CYT997 is shown to potently inhibit the proliferation of vascular endothelial growth factor-stimulated human umbilical vein endothelial cells (IC(50) 3.7 ?? 1.8 nM) and cause significant morphological changes at 100 nM, including membrane blebbing.

More Information Supplier Page

Cyt387 50mg 50mg  | Purity Not Available

Adooq Bioscience

CYT387 is an inhibitor of Janus kinases JAK1 and JAK2, acting as an ATP competitor with IC50 values of 11 and 18 nM, respectively.

More Information Supplier Page

Cyt387 25mg 25mg  | Purity Not Available

Adooq Bioscience

CYT387 is an inhibitor of Janus kinases JAK1 and JAK2, acting as an ATP competitor with IC50 values of 11 and 18 nM, respectively.

More Information Supplier Page

Cytarabine 50mg 50mg  | Purity Not Available

Adooq Bioscience

Cytarabine inhibits DNA replication by incorporating into DNA (IC50 = 0.04 ??M in L1210 and CEM cell lines).

More Information Supplier Page

Cytarabine 500mg 500mg  | Purity Not Available

Adooq Bioscience

Cytarabine inhibits DNA replication by incorporating into DNA (IC50 = 0.04 ??M in L1210 and CEM cell lines).

More Information Supplier Page

Daidzein 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Daidzein structurally belongs to the group of isoflavones. Daidzein can be converted to its end metabolite S-equol in some humans based on the presence of certain intestinal bacteria. Based on several decades of research, S-equol has potential for significant health benefits.

More Information Supplier Page

Daidzein 100mg 100mg  | Purity Not Available

Adooq Bioscience

Daidzein structurally belongs to the group of isoflavones. Daidzein can be converted to its end metabolite S-equol in some humans based on the presence of certain intestinal bacteria. Based on several decades of research, S-equol has potential for significant health benefits.

More Information Supplier Page